The lung as a target organ of graft-versus-host disease

Seminars in Hematology

Volumn 43, Issue 1, 2006, Pages 42-52

  Yanik, Gregory ^a   Cooke, Kenneth R ^a,b,c,d  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b NATIONAL MARROW DONOR PROGRAM   (United States)

^c Robert Wood Johnson Minority Faculty Development Program   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZATHIOPRINE; AZITHROMYCIN; BUSULFAN; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; ETANERCEPT; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; METHOTREXATE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ACUTE LUNG INJURY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIMICROBIAL ACTIVITY; AUTOTRANSPLANTATION; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHODILATATION; CAPILLARY LEAK SYNDROME; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; GRAFT VERSUS HOST REACTION; HEMOFILTRATION; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; IDIOPATHIC PNEUMONIA SYNDROME; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTENSIVE CARE; INTERSTITIAL PNEUMONIA; LUNG; LUNG HEMORRHAGE; LUNG INFECTION; LUNG INJURY; LUNG TOXICITY; MACROPHAGE; MORBIDITY; MORTALITY; NONHUMAN; OXYGEN THERAPY; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK FACTOR; T LYMPHOCYTE; TARGET ORGAN; TOXICITY; TRANSPLANTATION;

EID: 30344446001     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2005.09.004     Document Type: Article

References (86)

1. J. Clark, J. Hansen, M. Hertz, R. Parkman, L. Jensen, H. Peavy NHLBI Workshop Summary Idiopathic pneumonia syndrome after bone marrow transplantation Am Rev Respir Dis 147 1993 1601 1606
2. S. Crawford, R. Hackman Clinical course of idiopathic pneumonia after bone marrow transplantation Am Rev Respir Dis 147 1993 1393 1400
3. R.S. Weiner, M.B. Mortimer, R.P. Gale, E. Gluckman, H.E.M. Kay, J.J. Kolb Interstitial pneumonitis after bone marrow transplantation Ann Intern Med 104 1986 168 175
4. S. Crawford, G. Longton, R. Storb Acute graft versus host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia Bone Marrow Transplant 12 1993 225 231
5. S.P. Kantrow, R.C. Hackman, M. Boeckh Idiopathic pneumonia syndrome Changing spectrum of lung injury after marrow transplantation Transplantation 63 1997 1079 1086
6. B. Afessa, M.R. Litzow, A. Tefferi Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation Bone Marrow Transplant 28 2001 425 434
7. K.R. Schultz, G.J. Green, D. Wensley, M.A. Sargent, J.F. Magee, J.J. Spinelli Obstructive lung disease in children after allogeneic bone marrow transplantation Blood 84 1994 3212 3220
8. S.W. Crawford, M. Pepe, D. Lin Abnormalities of pulmonary function tests after marrow transplantation predict nonrelapse mortality Am J Respir Crit Care Med 152 1995 690 695
9. K. Sullivan, M. Mori, J. Sanders, M. Siadak, R.P. Witherspoon, C. Anasetti Late complications of allogeneic and autologous bone marrow transplantation Bone Marrow Transplant 10 1992 127 134
10. J. Sanchez, A. Torres, J. Serrano, J. Romain, C. Martin, L. Perula Long term follow up of immunosuppressive treatment for obstructive airway disease after allogeneic bone marrow transplantation Bone Marrow Transplant 20 1997 403 408
11. M. Badier, C. Guillot, S. Delpierre Pulmonary function changes 100 days and one year after bone marrow transplantation Bone Marrow Transplant 12 1993 457 461
12. J.R. Wingard, E.D. Mellits, M.B. Sostrin, D.Y. Chen, W.H. Burns, G.W. Santos Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution Medicine 67 1988 175 186
13. S.A. Yousem The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients Hum Pathol 26 1995 668 675
14. J.G. Clark, D.K. Madtes, T.R. Martin, R.C. Hackman, A.L. Farrand, S.W. Crawford Idiopathic pneumonia after bone marrow transplantation Cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment Crit Care Med 27 1999 1800 1806
15. G. Yanik, B. Hellerstedt, J. Custer, R. Hutchinson, D. Kwon, J.L. Ferrara Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation Biol Blood Marrow Transplant 8 2002 395 400
16. R.A. Robbins, J. Linder, M.G. Stahl, A.B. Thompson, W. Haire, A. Kessinger Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients Am J Med 87 1989 511 518
17. I.D. Lewis, T. DeFor, D.J. Weisdorf Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation Cryptic etiology and uncertain therapy Bone Marrow Transplant 26 2000 539 543
18. S.A. Capizzi, S. Kumar, N.E. Huneke, M.A. Gertz, D.J. Inwards, M.R. Litzow Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation Bone Marrow Transplant 27 2001 1299 1303
19. S.W. Wilczynski, J.J. Erasmus, W.P. Petros, J.J. Vredenburgh, R.J. Foltz Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer Am J Respir Crit Care Med 157 1998 565 573
20. K.S. Bhalla, S.W. Wilczynski, A.M. Abushamaa, W.P. Petros, C.S. McDonald, J.S. Loftis Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support Am J Respir Crit Care Med 161 2000 17 25
21. R.A. Cahill, T.R. Spitzer, A. Mazumder Marrow engraftment and clincial manifestations of capillary leak syndrome Bone Marrow Transplant 18 1996 177 184
22. R.S. Weiner, M.M. Horowitz, R.P. Gale, K.A. Dicke, D.W. van Bekkum, T. Masaoka Risk factors for interstitial pneumonitis following bone marrow transplantation for severe aplastic anemia Br J Haematol 71 1989 535 543
23. A. Della Volpe, A.J. Ferreri, C. Annaloro, P. Mangili, A. Rosso, R. Calandrino Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation Int J Radiat Oncol Biol Phys 52 2002 483 488
24. T. Fukuda, R.C. Hackman, K.A. Guthrie, B.M. Sandmaier, M. Boeckh, M.B. Maris Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation Blood 102 2003 2777 2785
25. J.D. Down, P. Mauch, M. Warhol, S. Neben, J.L.M. Ferrara The effect of donor T lymphocytes and total-body irradiation on hemopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transplantation Transplantation 54 1992 802 808
26. G. Shankar, D.A. Cohen Idiopathic pneumonia syndrome after bone marrow transplantation The role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis Int J Exp Pathol 82 2001 101 113
27. P. Piguet, M. Collart, G. Grau, A. Sappino, P. Vassalli Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis Nature 344 1990 245 247
28. J. Schmidt, C.N. Pliver, J.L. Lepe-Zuniga, I. Green, I. Gery Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin-1. A potential role for interleukin-1 in the pathogenesis of silicosis J Clin Invest 73 1984 1462 1472
29. P. Suter, S. Suter, E. Girardin, P. Roux-Lombard, G. Grau, J. Dayer High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock or sepsis Am Rev Respir Dis 145 1992 1016 1022
30. M. Bortin, O. Ringden, M. Horowitz, C. Rozman, R. Weiner, A. Rimm Temporal relationships between the major complications of bone marrow transplantation for leukemia Bone Marrow Transplant 4 1989 339 344
31. W. Beschorner, R. Saral, G. Hutchins, P. Tutschka, G. Santos Lymphocytic bronchitis associated with graft versus host disease in recipients of bone marrow transplants N Engl J Med 299 1978 1030 1036
32. P.F. Piguet, G.E. Grau, M.A. Collart Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor MRNA and chronic interstitial pneumonitis Lab Invest 61 1989 37 45
33. J.G. Clark, D.K. Madtes, R.C. Hackman, W. Chen, M.A. Cheever, P.J. Martin Lung injury induced by alloreactive Th1 cells is characterized by host-derived mononuclear cell inflammation and activation of alveolar macrophages J Immunol 161 1998 1913 1920
34. K.R. Cooke, L. Kobzik, T.R. Martin, J. Brewer, J. Delmonte, J.M. Crawford An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin Blood 88 1996 3230 3239
35. K.R. Cooke, W. Krenger, G.R. Hill, T. Martin, L. Kobzik, J. Brewer Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation Blood 92 1998 2571 2580
36. R.C. Hackman, G.E. Sale Large airway inflammation as a possible manifestation of a pulmonary graft-versus-host reaction in bone marrow allograft recipients Lab Invest 44 1981 26A
37. R. Connor, N. Ramsay, P. McGlave, D. Snover, J. Kersey, B. Burke Pulmonary pathology in bone marrow transplant recipients Lab Invest 46 1982 3
38. A. Panoskaltsis-Mortari, P.A. Taylor, T.M. Yaegar, O.D. Wangensteen, P.B. Bitterman, D.H. Ingbar The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogenic recipients are due to donor T cell infusion and potentiated by cyclophoshamide J Clin Invest 100 1997 1015 1027
39. D.J. Curtis, A. Smale, F. Thien, A.P. Schwarer, J. Szer Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation Bone Marrow Transplant 16 1995 169 173
40. J.G. Clark, D.A. Schwartz, N. Flournoy, K.M. Sullivan, S.W. Crawford, E.D. Thomas Risk factors for air-flow obstruction in recipients of bone marrow transplants Ann Intern Med 107 1987 648 656
41. G.C. Hildebrandt, L.A. Corrion, K.M. Olkiewicz, B. Lu, K. Lowler, U.A. Duffner Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome J Immunol 173 2004 2050 2059
42. K. Cooke, L. Kobzik, T. Teshima, K. Lowler, S. Clouthier, J. Ferrara A role for Fas-Fas ligand but not perforin mediated cytolysis in the development of experimental idiopathic pneumonia syndrome Blood 96 2000 768a
43. G.C. Hildebrandt, K.M. Olkiewicz, L.A. Corrion, Y. Chang, S.G. Clouthier, C. Liu Donor-derived TNF-alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation Blood 104 2004 586 593
44. M. Dupuis, D.M. McDonald Dendritic-cell regulation of lung immunity Am J Respir Cell Mol Biol 17 1997 284 286
45. P.J. Christensen, L.R. Armstrong, J.J. Fak, G.H. Chen, R.A. McDonald, G.B. Toews Regulation of rat pulmonary dendritic cell immunostimulatory activity by alveolar epithelial cell-derived granulocyte macrophage colony-stimulating factor Am J Respir Cell Mol Biol 13 1995 426 433
46. J.M. van Haarst, H.J. de Wit, H.A. Drexhage, H.C. Hoogsteden Distribution and immunophenotype of mononuclear and dendritic cells in the human lung Am J Respir Cell Mol Biol 10 1994 487 492
47. S.A. Yousem, L. Ray, I.L. Paradis, J.A. Dauber, B.P. Griffith Potential role of dendritic cells in bronchiolitis obliterans in heart-lung transplantation Ann Thorac Surg 49 1990 424 428
48. P.G. Holt, S. Haining, D.J. Nelson, J.D. Sedgwick Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways J Immunol 153 1994 256 261
49. P.F. Piguet, G.E. Grau, B. Allet, P.J. Vassalli Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-versus-host disease J Exp Med 166 1987 1280 1289
50. K.R. Cooke, G.R. Hill, A. Gerbitz, L. Kobzik, T.R. Martin, J.M. Crawford Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation Transplantation 70 2000 272 279
51. K.R. Cooke, G.R. Hill, A. Gerbitz, L. Kobzik, T.R. Martin, J.M. Crawford Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome Potential role for a gut-lung axis of inflammation J Immunol 165 2000 6612 6619
52. K. Cooke, G. Hill, J. Crawford, D. Bungard, Y. Brinson, J. Delmonte Jr. Tumor necrosis factor-a production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft versus host disease J Clin Invest 102 1998 1882 1891
53. K. Hattori, T. Hirano, H. Miyajima, N. Yamakawa, M. Tateno, K. Oshimi Differential effects of anti-Fas ligand and anti-tumor necrosis factor-a antibodies on acute graft-versus-host disease pathologies Blood 91 1998 4051 4055
54. D.A. Vallera, P.A. Taylor, J.L. Vannice, A. Panoskaltsis-Mortari, B.R. Blazar Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice Transplantation 60 1995 1371 1374
55. J.G. Clark, J.B. Mandac, A.E. Dixon, P.J. Martin, R.C. Hackman, D.K. Madtes Neutralization of tumor necrosis factor-alpha action delays but does not prevent lung injury induced by alloreactive T helper 1 cells Transplantation 70 2000 39 43
56. I. Haddad, A. Panoskaltsis-Mortari, D. Ingbar, S. Yang, C. Milla, B. Blazar High levels of peroxynitrite are generated in the lungs of irradiated mice given cyclophosphamide and allogeneic T cells A potential mechanism of injury after marrow transplantation Am J Respir Cell Mol Biol 20 1999 1125 1135
57. G. Hill, J. Ferrara The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease Rationale for the use of cytokine shields in allogeneic bone marrow transplantation Blood 95 2000 2754 2759
58. K.R. Cooke, A. Gerbitz, J.M. Crawford, T. Teshima, G.R. Hill, A. Tesolin LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation J Clin Invest 107 2001 1581 1589
59. C. Fegan, C.H. Poynton, J.A. Whittaker The gut mucosal barrier in bone marrow transplantation Bone Marrow Transplant 5 1990 373 377
60. K.R. Cooke, K. Olkiewicz, N. Erickson, J.L. Ferrara The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease J Endotoxin Res 8 2002 441 448
61. U. Maus, S. Herold, H. Muth, R. Maus, L. Ermert, M. Ermert Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14 Am J Physiol Lung Cell Mol Physiol 280 2001 L58 L68
62. J.V. DiCarlo, S.R. Alexander, R. Agarwal, J.D. Schiffman Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy J Pediatr Hematol Oncol 25 2003 801 805
63. G.A. Yanik, J.E. Levine, J.L.M. Ferrara, J.P. Uberti, V.T. Ho, J.H. Antin Survival following etantercept therapy for the treatment of idiopathic pneumonia syndrome following allogeneic stem cell transplantation Blood 104 2004 104a
64. I. Cerveri, P. Fulgoni, G. Giorgiani, M.C. Zoia, M. Beccaria, C. Tinelli Lung function abnormalities after bone marrow transplantation in children Has the trend recently changed? Chest 120 2001 1900 1906
65. O. Ringden, M. Remberger, T. Ruutu, J. Nikoskelainen, L. Volin, L. Vindelov Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation Long-term results of a randomized trial in allogeneic marrow recipients with leukemia Blood 93 1999 2196 2201
66. D.D. Ralph, S.C. Springmeyer, K.M. Sullivan, R.C. Hackman, R. Storb, E.D. Thomas Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease Am Rev Respir Dis 129 1984 641 644
67. J.G. Clark, S.W. Crawford, D.K. Madtes, K.M. Sullivan Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course Ann Intern Med 111 1989 368 376
68. K.M. Sullivan, E. Agura, C. Anasetti, F. Appelbaum, C. Badger, S. Bearman Chronic graft-versus-host disease and other late complications of bone marrow transplantation Semin Hematol 28 1991 250 259
69. M.P. d'Alessandro, H.P. Kozakewich, K.R. Cooke, G.A. Taylor Radiologic-pathologic conference of Children's Hospital Boston New pulmonary nodules in a child undergoing treatment for a solid malignancy Pediatr Radiol 26 1996 19 21
70. T.E. King Jr Overview of bronchiolitis Clin Chest Med 14 1993 607 610
71. G.C. Ooi, W.C. Peh, M. Ip High-resolution computed tomography of bronchiolitis obliterans syndrome after bone marrow transplantation Respiration 65 1998 187 191
72. A.A. Bankier, A. Van Muylem, C. Knoop, M. Estenne, P.A. Gevenois Bronchiolitis obliterans syndrome in heart-lung transplant recipients Diagnosis with expiratory CT Radiology 218 2001 533 539
73. A.Z. Dudek, H. Mahaseth, T.E. DeFor, D.J. Weisdorf Bronchiolitis obliterans in chronic graft-versus-host disease Analysis of risk factors and treatment outcomes Biol Blood Marrow Transplant 9 2003 657 666
74. T. Beinert, T. Dull, K. Wolf, E. Holler, C. Vogelmeier, J. Behr Late pulmonary impairment following allogeneic bone marrow transplantation Eur J Med Res 1 1996 343 348
75. H.K. Holland, J.R. Wingard, W.E. Beschorner, R. Saral, G.W. Santos Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-versus-host disease and low serum IgG Blood 72 1988 621 627
76. J.A. Belperio, B. DiGiovine, M.P. Keane, M.D. Burdick, Y. Ying Xue, D.J. Ross Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients Transplantation 73 2002 591 599
77. A. Elssner, F. Jaumann, S. Dobmann, J. Behr, M. Schwaiblmair, H. Reichenspurner Munich Lung Transplant Group Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome Proinflammatory role of bronchial epithelial cells Transplantation 70 2000 362 367
78. R. Coker, G. Laurent Pulmonary fibrosis Cytokines in the balance Eur Respir J 11 1998 1218 1221
79. P. Sime, R. Marr, D. Gauldie, Z. Xing, B. Hewlett, F. Graham Transfer of tumor necrosis factor-a to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-b1 and myofibroblasts Am J Pathol 153 1998 825 832
80. Y. Miyazaki, K. Araki, C. Vesin, I. Garcia, Y. Kapanci, J. Whitsett Expression of a tumor necrosis factor-a transgene in murine lung causes lymphocytic and fibrosing alveolitis J Clin Invest 96 1995 250 259
81. L. Payne, C.K. Chan, G. Fyles, R.H. Hyland, P. Bafundi, M. Yueng Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation Chest 104 1993 114 118
82. G.M. Verleden, L.J. Dupont Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation Transplantation 77 2004 1465 1467
83. S.G. Gerhardt, J.F. McDyer, R.E. Girgis, J.V. Conte, S.C. Yang, J.B. Orens Maintenance azithromycin therapy for bronchiolitis obliterans syndrome Results of a pilot study Am J Respir Crit Care Med 168 2003 121 125
84. M. Khalid, A. Al Saghir, S. Saleemi, S. Al Dammas, M. Zeitouni, A. Al Mobeireek Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation A preliminary study Eur Respir J 25 2005 490 493
85. K.Y. Chiang, S. Abhyankar, K. Bridges, K. Godder, J.P. Henslee-Downey Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease Transplantation 73 2002 665 667
86. G. Yanik, J. Uberti, J.L.M. Ferrara, E. White, B. Hellerstedt, T. Standiford Etanercept for sub-acute lung injury following allogeneic stem cell transplantation Blood 102 2003 471a